Intellectual Property Partner, Paris
Pauline heads the IP/TMT practice of Linklaters in Paris and has considerable experience in IP litigation. She focuses on handling complex cross-border patent and trademark litigations, notably in the healthcare and telecommunications sectors. She assists major clients in all types of proceedings, including preliminary injunctions, seizures (saisies-contrefaçon), revocation and infringement actions, arbitration and mediation, often in a global context (parallel litigation in the US, pending oppositions before the EPO). Pauline also assists clients with negotiating and drafting contracts related to intellectual property rights (JV agreements, R&D agreements, co-existence agreements) and works in close connection with our competition and arbitration experts.
Pauline co-heads the Patent Commission of the French group of AIPPI, as well as the Standing Committee on Patents and Standards. She is also a member of EPLAW (European Patent Lawyers association), APRAM and LES.
Pauline is ranked amongst France’s best IP lawyers. Ranked Band 2 by Chambers, she is described as a “team player”, having “long standing experience (...) and being “easy to talk to” (Chambers 2015). Clients “praise her strong analytical skills and her responsiveness on files”. Described as “a real expert” who “knows IP in depth”, “easy to work with her because she understands very quickly the stakes of a question and gives strong and sound advice." (Chambers 2017).
Décideurs ranked Pauline and her team as “excellent” both for patent and trademark litigation, with the following comment: “A stand-out year for Pauline Debré and her team, becoming the team of choice for big names in the pharmaceutical industry to settle trademark and patent disputes (...)”.
Recent experience includes:
- Assisting and representing a US pharmaceutical company in a revocation action about a patent covering a nanoparticle composition of an anti-emetic drug;
- Assisting and representing a dental pharmaceuticals and consumables company in a patent dispute related to medical devices (syringe tips) involving France, Germany and the UK;
- Advising a food and healthcare company in connection with the creation of a joint venture with dedicated to the microbiome diagnosis, negotiating related license and service agreements;
- Assisting and representing a French company in a dispute relating to patent and know how covering smart meters (infringement proceedings and mediation);
- Assisting and representing a US pharmaceutical company in a global dispute, involving the US, UK, France, Germany, Switzerland, India, Mexico, relating to the use of its corporate name, business name and trademarks;
- Assisting and representing a US pharmaceutical company in a dispute related to additional remunerations for patents in the field of hepatitis treatment;
- Advising and assisting a company specialised in the development of M2M equipment and services in a dispute and arbitration related to essential patent licences covering 2G and 3G standards;
- Assisting a French group specialised in the design, manufacture and marketing of upmarket lingerie in trademark and patent infringement actions and in anti-counterfeiting strategy worldwide;
- Advising a major cosmetic group on the IP aspects of the sale of a brand;
- Advising a private equity fund on the potential acquisition of a food business in a context of carve out
Recent publications and conferences
- "The Frandomnes of Essential Patents", Propriété Industrielle, Lexis Nexis, April 2018
- “Applying statutes of limitation to patent revocation actions in France”, EPLAW blog, November 2017 (http://eplaw.org/fr-applying-statutes-of-limitations-to-patent-revocations-in-france/)
- "Keeping up with the changing landscape of FRAND", Global Patent Forum, MIP London, March 2017
- “The UPC will survive the Brexit”, La lettre des juristes d’affaires, January 2017
- "Patent enforcement : alternative to Court proceedings", Global Patent Forum, MIP Paris, September 2016
- “The infringement action by a standard-essential patent holder”, June 2016 (Concurrences, Competition Law review)
French, English, Spanish